Global Orphan Drugs for Adults Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Orphan Drugs for Adults, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orphan Drugs for Adults.
The Orphan Drugs for Adults market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orphan Drugs for Adults market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orphan Drugs for Adults companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orphan Drugs for Adults companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Orphan Drugs for Adults market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orphan Drugs for Adults market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orphan Drugs for Adults companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Abbvie Inc.
- Orpharma
- Amgen Inc.
- Recordati SpA
- Novartis
- Celgene
- Amryt Pharma Plc.
- Johnson & Johnson
- GSK Plc.
- Bristol-Myers Squibb Company
- Roche Holding
- Sanofi
- Takeda
- Pfizer
- Vertex Pharmaceuticals
- Oncology Drugs
- Gastrointestinal Drugs
- Neurology Drugs
- Cardio-vascular Drugs
- Others
- Hospital Pharmacies
- Retail pharmacies
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orphan Drugs for Adults companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orphan Drugs for Adults Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Orphan Drugs for Adults Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Orphan Drugs for Adults Market Perspective (2018-2029)
2.2 Orphan Drugs for Adults Growth Trends by Region
2.2.1 Global Orphan Drugs for Adults Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Orphan Drugs for Adults Historic Market Size by Region (2018-2023)
2.2.3 Orphan Drugs for Adults Forecasted Market Size by Region (2024-2029)
2.3 Orphan Drugs for Adults Market Dynamics
2.3.1 Orphan Drugs for Adults Industry Trends
2.3.2 Orphan Drugs for Adults Market Drivers
2.3.3 Orphan Drugs for Adults Market Challenges
2.3.4 Orphan Drugs for Adults Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Orphan Drugs for Adults Players by Revenue
3.1.1 Global Top Orphan Drugs for Adults Players by Revenue (2018-2023)
3.1.2 Global Orphan Drugs for Adults Revenue Market Share by Players (2018-2023)
3.2 Global Orphan Drugs for Adults Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Orphan Drugs for Adults Revenue
3.4 Global Orphan Drugs for Adults Market Concentration Ratio
3.4.1 Global Orphan Drugs for Adults Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orphan Drugs for Adults Revenue in 2022
3.5 Orphan Drugs for Adults Key Players Head office and Area Served
3.6 Key Players Orphan Drugs for Adults Product Solution and Service
3.7 Date of Enter into Orphan Drugs for Adults Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ORPHAN DRUGS FOR ADULTS BREAKDOWN DATA BY TYPE
4.1 Global Orphan Drugs for Adults Historic Market Size by Type (2018-2023)
4.2 Global Orphan Drugs for Adults Forecasted Market Size by Type (2024-2029)
5 ORPHAN DRUGS FOR ADULTS BREAKDOWN DATA BY APPLICATION
5.1 Global Orphan Drugs for Adults Historic Market Size by Application (2018-2023)
5.2 Global Orphan Drugs for Adults Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Orphan Drugs for Adults Market Size (2018-2029)
6.2 North America Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Orphan Drugs for Adults Market Size by Country (2018-2023)
6.4 North America Orphan Drugs for Adults Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Orphan Drugs for Adults Market Size (2018-2029)
7.2 Europe Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Orphan Drugs for Adults Market Size by Country (2018-2023)
7.4 Europe Orphan Drugs for Adults Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Orphan Drugs for Adults Market Size (2018-2029)
8.2 Asia-Pacific Orphan Drugs for Adults Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Orphan Drugs for Adults Market Size by Region (2018-2023)
8.4 Asia-Pacific Orphan Drugs for Adults Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Orphan Drugs for Adults Market Size (2018-2029)
9.2 Latin America Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Orphan Drugs for Adults Market Size by Country (2018-2023)
9.4 Latin America Orphan Drugs for Adults Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Orphan Drugs for Adults Market Size (2018-2029)
10.2 Middle East & Africa Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Orphan Drugs for Adults Market Size by Country (2018-2023)
10.4 Middle East & Africa Orphan Drugs for Adults Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Detail
11.1.2 Abbvie Inc. Business Overview
11.1.3 Abbvie Inc. Orphan Drugs for Adults Introduction
11.1.4 Abbvie Inc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.1.5 Abbvie Inc. Recent Development
11.2 Orpharma
11.2.1 Orpharma Company Detail
11.2.2 Orpharma Business Overview
11.2.3 Orpharma Orphan Drugs for Adults Introduction
11.2.4 Orpharma Revenue in Orphan Drugs for Adults Business (2018-2023)
11.2.5 Orpharma Recent Development
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Detail
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. Orphan Drugs for Adults Introduction
11.3.4 Amgen Inc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.3.5 Amgen Inc. Recent Development
11.4 Recordati SpA
11.4.1 Recordati SpA Company Detail
11.4.2 Recordati SpA Business Overview
11.4.3 Recordati SpA Orphan Drugs for Adults Introduction
11.4.4 Recordati SpA Revenue in Orphan Drugs for Adults Business (2018-2023)
11.4.5 Recordati SpA Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Orphan Drugs for Adults Introduction
11.5.4 Novartis Revenue in Orphan Drugs for Adults Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Orphan Drugs for Adults Introduction
11.6.4 Celgene Revenue in Orphan Drugs for Adults Business (2018-2023)
11.6.5 Celgene Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Detail
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Orphan Drugs for Adults Introduction
11.7.4 Amryt Pharma Plc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Orphan Drugs for Adults Introduction
11.8.4 Johnson & Johnson Revenue in Orphan Drugs for Adults Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK Plc.
11.9.1 GSK Plc. Company Detail
11.9.2 GSK Plc. Business Overview
11.9.3 GSK Plc. Orphan Drugs for Adults Introduction
11.9.4 GSK Plc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.9.5 GSK Plc. Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Detail
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Orphan Drugs for Adults Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Orphan Drugs for Adults Business (2018-2023)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Detail
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Orphan Drugs for Adults Introduction
11.11.4 Roche Holding Revenue in Orphan Drugs for Adults Business (2018-2023)
11.11.5 Roche Holding Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Orphan Drugs for Adults Introduction
11.12.4 Sanofi Revenue in Orphan Drugs for Adults Business (2018-2023)
11.12.5 Sanofi Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Orphan Drugs for Adults Introduction
11.13.4 Takeda Revenue in Orphan Drugs for Adults Business (2018-2023)
11.13.5 Takeda Recent Development
11.14 Pfizer
11.14.1 Pfizer Company Detail
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Orphan Drugs for Adults Introduction
11.14.4 Pfizer Revenue in Orphan Drugs for Adults Business (2018-2023)
11.14.5 Pfizer Recent Development
11.15 Vertex Pharmaceuticals
11.15.1 Vertex Pharmaceuticals Company Detail
11.15.2 Vertex Pharmaceuticals Business Overview
11.15.3 Vertex Pharmaceuticals Orphan Drugs for Adults Introduction
11.15.4 Vertex Pharmaceuticals Revenue in Orphan Drugs for Adults Business (2018-2023)
11.15.5 Vertex Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orphan Drugs for Adults Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Orphan Drugs for Adults Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Orphan Drugs for Adults Market Perspective (2018-2029)
2.2 Orphan Drugs for Adults Growth Trends by Region
2.2.1 Global Orphan Drugs for Adults Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Orphan Drugs for Adults Historic Market Size by Region (2018-2023)
2.2.3 Orphan Drugs for Adults Forecasted Market Size by Region (2024-2029)
2.3 Orphan Drugs for Adults Market Dynamics
2.3.1 Orphan Drugs for Adults Industry Trends
2.3.2 Orphan Drugs for Adults Market Drivers
2.3.3 Orphan Drugs for Adults Market Challenges
2.3.4 Orphan Drugs for Adults Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Orphan Drugs for Adults Players by Revenue
3.1.1 Global Top Orphan Drugs for Adults Players by Revenue (2018-2023)
3.1.2 Global Orphan Drugs for Adults Revenue Market Share by Players (2018-2023)
3.2 Global Orphan Drugs for Adults Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Orphan Drugs for Adults Revenue
3.4 Global Orphan Drugs for Adults Market Concentration Ratio
3.4.1 Global Orphan Drugs for Adults Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orphan Drugs for Adults Revenue in 2022
3.5 Orphan Drugs for Adults Key Players Head office and Area Served
3.6 Key Players Orphan Drugs for Adults Product Solution and Service
3.7 Date of Enter into Orphan Drugs for Adults Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ORPHAN DRUGS FOR ADULTS BREAKDOWN DATA BY TYPE
4.1 Global Orphan Drugs for Adults Historic Market Size by Type (2018-2023)
4.2 Global Orphan Drugs for Adults Forecasted Market Size by Type (2024-2029)
5 ORPHAN DRUGS FOR ADULTS BREAKDOWN DATA BY APPLICATION
5.1 Global Orphan Drugs for Adults Historic Market Size by Application (2018-2023)
5.2 Global Orphan Drugs for Adults Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Orphan Drugs for Adults Market Size (2018-2029)
6.2 North America Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Orphan Drugs for Adults Market Size by Country (2018-2023)
6.4 North America Orphan Drugs for Adults Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Orphan Drugs for Adults Market Size (2018-2029)
7.2 Europe Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Orphan Drugs for Adults Market Size by Country (2018-2023)
7.4 Europe Orphan Drugs for Adults Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Orphan Drugs for Adults Market Size (2018-2029)
8.2 Asia-Pacific Orphan Drugs for Adults Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Orphan Drugs for Adults Market Size by Region (2018-2023)
8.4 Asia-Pacific Orphan Drugs for Adults Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Orphan Drugs for Adults Market Size (2018-2029)
9.2 Latin America Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Orphan Drugs for Adults Market Size by Country (2018-2023)
9.4 Latin America Orphan Drugs for Adults Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Orphan Drugs for Adults Market Size (2018-2029)
10.2 Middle East & Africa Orphan Drugs for Adults Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Orphan Drugs for Adults Market Size by Country (2018-2023)
10.4 Middle East & Africa Orphan Drugs for Adults Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Detail
11.1.2 Abbvie Inc. Business Overview
11.1.3 Abbvie Inc. Orphan Drugs for Adults Introduction
11.1.4 Abbvie Inc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.1.5 Abbvie Inc. Recent Development
11.2 Orpharma
11.2.1 Orpharma Company Detail
11.2.2 Orpharma Business Overview
11.2.3 Orpharma Orphan Drugs for Adults Introduction
11.2.4 Orpharma Revenue in Orphan Drugs for Adults Business (2018-2023)
11.2.5 Orpharma Recent Development
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Detail
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. Orphan Drugs for Adults Introduction
11.3.4 Amgen Inc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.3.5 Amgen Inc. Recent Development
11.4 Recordati SpA
11.4.1 Recordati SpA Company Detail
11.4.2 Recordati SpA Business Overview
11.4.3 Recordati SpA Orphan Drugs for Adults Introduction
11.4.4 Recordati SpA Revenue in Orphan Drugs for Adults Business (2018-2023)
11.4.5 Recordati SpA Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Orphan Drugs for Adults Introduction
11.5.4 Novartis Revenue in Orphan Drugs for Adults Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Orphan Drugs for Adults Introduction
11.6.4 Celgene Revenue in Orphan Drugs for Adults Business (2018-2023)
11.6.5 Celgene Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Detail
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Orphan Drugs for Adults Introduction
11.7.4 Amryt Pharma Plc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Orphan Drugs for Adults Introduction
11.8.4 Johnson & Johnson Revenue in Orphan Drugs for Adults Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK Plc.
11.9.1 GSK Plc. Company Detail
11.9.2 GSK Plc. Business Overview
11.9.3 GSK Plc. Orphan Drugs for Adults Introduction
11.9.4 GSK Plc. Revenue in Orphan Drugs for Adults Business (2018-2023)
11.9.5 GSK Plc. Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Detail
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Orphan Drugs for Adults Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Orphan Drugs for Adults Business (2018-2023)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Detail
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Orphan Drugs for Adults Introduction
11.11.4 Roche Holding Revenue in Orphan Drugs for Adults Business (2018-2023)
11.11.5 Roche Holding Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Orphan Drugs for Adults Introduction
11.12.4 Sanofi Revenue in Orphan Drugs for Adults Business (2018-2023)
11.12.5 Sanofi Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Orphan Drugs for Adults Introduction
11.13.4 Takeda Revenue in Orphan Drugs for Adults Business (2018-2023)
11.13.5 Takeda Recent Development
11.14 Pfizer
11.14.1 Pfizer Company Detail
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Orphan Drugs for Adults Introduction
11.14.4 Pfizer Revenue in Orphan Drugs for Adults Business (2018-2023)
11.14.5 Pfizer Recent Development
11.15 Vertex Pharmaceuticals
11.15.1 Vertex Pharmaceuticals Company Detail
11.15.2 Vertex Pharmaceuticals Business Overview
11.15.3 Vertex Pharmaceuticals Orphan Drugs for Adults Introduction
11.15.4 Vertex Pharmaceuticals Revenue in Orphan Drugs for Adults Business (2018-2023)
11.15.5 Vertex Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Orphan Drugs for Adults Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Orphan Drugs for Adults Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Orphan Drugs for Adults Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Orphan Drugs for Adults Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Orphan Drugs for Adults Market Share by Region (2018-2023)
Table 11. Global Orphan Drugs for Adults Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Orphan Drugs for Adults Market Share by Region (2024-2029)
Table 13. Orphan Drugs for Adults Market Trends
Table 14. Orphan Drugs for Adults Market Drivers
Table 15. Orphan Drugs for Adults Market Challenges
Table 16. Orphan Drugs for Adults Market Restraints
Table 17. Global Orphan Drugs for Adults Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Orphan Drugs for Adults Market Share by Players (2018-2023)
Table 19. Global Top Orphan Drugs for Adults Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs for Adults as of 2022)
Table 20. Ranking of Global Top Orphan Drugs for Adults Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Orphan Drugs for Adults Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Orphan Drugs for Adults Product Solution and Service
Table 24. Date of Enter into Orphan Drugs for Adults Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Orphan Drugs for Adults Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Orphan Drugs for Adults Revenue Market Share by Type (2018-2023)
Table 28. Global Orphan Drugs for Adults Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Orphan Drugs for Adults Revenue Market Share by Type (2024-2029)
Table 30. Global Orphan Drugs for Adults Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Orphan Drugs for Adults Revenue Market Share by Application (2018-2023)
Table 32. Global Orphan Drugs for Adults Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Orphan Drugs for Adults Revenue Market Share by Application (2024-2029)
Table 34. North America Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Orphan Drugs for Adults Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Orphan Drugs for Adults Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Orphan Drugs for Adults Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 49. Abbvie Inc. Company Detail
Table 50. Abbvie Inc. Business Overview
Table 51. Abbvie Inc. Orphan Drugs for Adults Product
Table 52. Abbvie Inc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 53. Abbvie Inc. Recent Development
Table 54. Orpharma Company Detail
Table 55. Orpharma Business Overview
Table 56. Orpharma Orphan Drugs for Adults Product
Table 57. Orpharma Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 58. Orpharma Recent Development
Table 59. Amgen Inc. Company Detail
Table 60. Amgen Inc. Business Overview
Table 61. Amgen Inc. Orphan Drugs for Adults Product
Table 62. Amgen Inc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 63. Amgen Inc. Recent Development
Table 64. Recordati SpA Company Detail
Table 65. Recordati SpA Business Overview
Table 66. Recordati SpA Orphan Drugs for Adults Product
Table 67. Recordati SpA Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 68. Recordati SpA Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Orphan Drugs for Adults Product
Table 72. Novartis Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Celgene Company Detail
Table 75. Celgene Business Overview
Table 76. Celgene Orphan Drugs for Adults Product
Table 77. Celgene Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 78. Celgene Recent Development
Table 79. Amryt Pharma Plc. Company Detail
Table 80. Amryt Pharma Plc. Business Overview
Table 81. Amryt Pharma Plc. Orphan Drugs for Adults Product
Table 82. Amryt Pharma Plc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 83. Amryt Pharma Plc. Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Orphan Drugs for Adults Product
Table 87. Johnson & Johnson Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. GSK Plc. Company Detail
Table 90. GSK Plc. Business Overview
Table 91. GSK Plc. Orphan Drugs for Adults Product
Table 92. GSK Plc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 93. GSK Plc. Recent Development
Table 94. Bristol-Myers Squibb Company Company Detail
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Orphan Drugs for Adults Product
Table 97. Bristol-Myers Squibb Company Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Roche Holding Company Detail
Table 100. Roche Holding Business Overview
Table 101. Roche Holding Orphan Drugs for Adults Product
Table 102. Roche Holding Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 103. Roche Holding Recent Development
Table 104. Sanofi Company Detail
Table 105. Sanofi Business Overview
Table 106. Sanofi Orphan Drugs for Adults Product
Table 107. Sanofi Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 108. Sanofi Recent Development
Table 109. Takeda Company Detail
Table 110. Takeda Business Overview
Table 111. Takeda Orphan Drugs for Adults Product
Table 112. Takeda Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. Pfizer Company Detail
Table 115. Pfizer Business Overview
Table 116. Pfizer Orphan Drugs for Adults Product
Table 117. Pfizer Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 118. Pfizer Recent Development
Table 119. Vertex Pharmaceuticals Company Detail
Table 120. Vertex Pharmaceuticals Business Overview
Table 121. Vertex Pharmaceuticals Orphan Drugs for Adults Product
Table 122. Vertex Pharmaceuticals Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 123. Vertex Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Global Orphan Drugs for Adults Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Orphan Drugs for Adults Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Orphan Drugs for Adults Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Orphan Drugs for Adults Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Orphan Drugs for Adults Market Share by Region (2018-2023)
Table 11. Global Orphan Drugs for Adults Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Orphan Drugs for Adults Market Share by Region (2024-2029)
Table 13. Orphan Drugs for Adults Market Trends
Table 14. Orphan Drugs for Adults Market Drivers
Table 15. Orphan Drugs for Adults Market Challenges
Table 16. Orphan Drugs for Adults Market Restraints
Table 17. Global Orphan Drugs for Adults Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Orphan Drugs for Adults Market Share by Players (2018-2023)
Table 19. Global Top Orphan Drugs for Adults Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs for Adults as of 2022)
Table 20. Ranking of Global Top Orphan Drugs for Adults Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Orphan Drugs for Adults Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Orphan Drugs for Adults Product Solution and Service
Table 24. Date of Enter into Orphan Drugs for Adults Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Orphan Drugs for Adults Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Orphan Drugs for Adults Revenue Market Share by Type (2018-2023)
Table 28. Global Orphan Drugs for Adults Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Orphan Drugs for Adults Revenue Market Share by Type (2024-2029)
Table 30. Global Orphan Drugs for Adults Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Orphan Drugs for Adults Revenue Market Share by Application (2018-2023)
Table 32. Global Orphan Drugs for Adults Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Orphan Drugs for Adults Revenue Market Share by Application (2024-2029)
Table 34. North America Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Orphan Drugs for Adults Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Orphan Drugs for Adults Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Orphan Drugs for Adults Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Orphan Drugs for Adults Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Orphan Drugs for Adults Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Orphan Drugs for Adults Market Size by Country (2024-2029) & (US$ Million)
Table 49. Abbvie Inc. Company Detail
Table 50. Abbvie Inc. Business Overview
Table 51. Abbvie Inc. Orphan Drugs for Adults Product
Table 52. Abbvie Inc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 53. Abbvie Inc. Recent Development
Table 54. Orpharma Company Detail
Table 55. Orpharma Business Overview
Table 56. Orpharma Orphan Drugs for Adults Product
Table 57. Orpharma Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 58. Orpharma Recent Development
Table 59. Amgen Inc. Company Detail
Table 60. Amgen Inc. Business Overview
Table 61. Amgen Inc. Orphan Drugs for Adults Product
Table 62. Amgen Inc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 63. Amgen Inc. Recent Development
Table 64. Recordati SpA Company Detail
Table 65. Recordati SpA Business Overview
Table 66. Recordati SpA Orphan Drugs for Adults Product
Table 67. Recordati SpA Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 68. Recordati SpA Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Orphan Drugs for Adults Product
Table 72. Novartis Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Celgene Company Detail
Table 75. Celgene Business Overview
Table 76. Celgene Orphan Drugs for Adults Product
Table 77. Celgene Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 78. Celgene Recent Development
Table 79. Amryt Pharma Plc. Company Detail
Table 80. Amryt Pharma Plc. Business Overview
Table 81. Amryt Pharma Plc. Orphan Drugs for Adults Product
Table 82. Amryt Pharma Plc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 83. Amryt Pharma Plc. Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Orphan Drugs for Adults Product
Table 87. Johnson & Johnson Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. GSK Plc. Company Detail
Table 90. GSK Plc. Business Overview
Table 91. GSK Plc. Orphan Drugs for Adults Product
Table 92. GSK Plc. Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 93. GSK Plc. Recent Development
Table 94. Bristol-Myers Squibb Company Company Detail
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Orphan Drugs for Adults Product
Table 97. Bristol-Myers Squibb Company Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Roche Holding Company Detail
Table 100. Roche Holding Business Overview
Table 101. Roche Holding Orphan Drugs for Adults Product
Table 102. Roche Holding Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 103. Roche Holding Recent Development
Table 104. Sanofi Company Detail
Table 105. Sanofi Business Overview
Table 106. Sanofi Orphan Drugs for Adults Product
Table 107. Sanofi Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 108. Sanofi Recent Development
Table 109. Takeda Company Detail
Table 110. Takeda Business Overview
Table 111. Takeda Orphan Drugs for Adults Product
Table 112. Takeda Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. Pfizer Company Detail
Table 115. Pfizer Business Overview
Table 116. Pfizer Orphan Drugs for Adults Product
Table 117. Pfizer Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 118. Pfizer Recent Development
Table 119. Vertex Pharmaceuticals Company Detail
Table 120. Vertex Pharmaceuticals Business Overview
Table 121. Vertex Pharmaceuticals Orphan Drugs for Adults Product
Table 122. Vertex Pharmaceuticals Revenue in Orphan Drugs for Adults Business (2018-2023) & (US$ Million)
Table 123. Vertex Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Orphan Drugs for Adults Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Orphan Drugs for Adults Market Share by Type: 2022 VS 2029
Figure 3. Oncology Drugs Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Neurology Drugs Features
Figure 6. Cardio-vascular Drugs Features
Figure 7. Others Features
Figure 8. Global Orphan Drugs for Adults Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Orphan Drugs for Adults Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Orphan Drugs for Adults Report Years Considered
Figure 14. Global Orphan Drugs for Adults Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Orphan Drugs for Adults Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Orphan Drugs for Adults Market Share by Region: 2022 VS 2029
Figure 17. Global Orphan Drugs for Adults Market Share by Players in 2022
Figure 18. Global Top Orphan Drugs for Adults Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs for Adults as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Orphan Drugs for Adults Revenue in 2022
Figure 20. North America Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 22. United States Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 26. Germany Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Orphan Drugs for Adults Market Share by Region (2018-2029)
Figure 34. China Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 42. Mexico Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 46. Turkey Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Abbvie Inc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 49. Orpharma Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 50. Amgen Inc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 51. Recordati SpA Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 53. Celgene Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 54. Amryt Pharma Plc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 56. GSK Plc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 58. Roche Holding Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 60. Takeda Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 61. Pfizer Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 62. Vertex Pharmaceuticals Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Global Orphan Drugs for Adults Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Orphan Drugs for Adults Market Share by Type: 2022 VS 2029
Figure 3. Oncology Drugs Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Neurology Drugs Features
Figure 6. Cardio-vascular Drugs Features
Figure 7. Others Features
Figure 8. Global Orphan Drugs for Adults Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Orphan Drugs for Adults Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Orphan Drugs for Adults Report Years Considered
Figure 14. Global Orphan Drugs for Adults Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Orphan Drugs for Adults Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Orphan Drugs for Adults Market Share by Region: 2022 VS 2029
Figure 17. Global Orphan Drugs for Adults Market Share by Players in 2022
Figure 18. Global Top Orphan Drugs for Adults Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs for Adults as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Orphan Drugs for Adults Revenue in 2022
Figure 20. North America Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 22. United States Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 26. Germany Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Orphan Drugs for Adults Market Share by Region (2018-2029)
Figure 34. China Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 42. Mexico Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Orphan Drugs for Adults Market Share by Country (2018-2029)
Figure 46. Turkey Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Orphan Drugs for Adults Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Abbvie Inc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 49. Orpharma Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 50. Amgen Inc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 51. Recordati SpA Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 53. Celgene Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 54. Amryt Pharma Plc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 56. GSK Plc. Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 58. Roche Holding Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 60. Takeda Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 61. Pfizer Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 62. Vertex Pharmaceuticals Revenue Growth Rate in Orphan Drugs for Adults Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
